Neurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricor's Novel Cell Therapy

Stock Information for Capricor Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.